|
America’s Emerging Health Care Crisis
Agenda
8:45 a.m. - 4 p.m.
May 12, 2004
Monsanto Auditorium, Life Sciences Center
8:30 - 8:45 a.m. - Registration/pick up materials
8:45 - 9 a.m. - Opening Remarks
Speakers: Dr. Glen T. Cameron, professor and Maxine Wilson Gregory Chair in Journalism Research, Missouri School of Journalism
Dr. Jerry Parker, director of the
Missouri Arthritis Rehabilitation Research and Training Center
9 - 10:10 a.m. - Arthritis for Beginners: Causes, Treatments, and Risks
Description: This session will examine arthritis, how serious the problem is, treatments, and causes, effects and common types of arthritis.
Speakers: James Cassidy, MD, MU Professor Emeritus and internationally renowned pediatric rheumatologist
Sara E. Walker, MD, rheumatologist and professor of Internal Medicine at the MU School of Medicine
Gregory M. Worsowicz, MD, MBA, chairman of the MU Department of Physical Medicine & Rehabilitation
10:10 - 10:25 a.m. - Break
10:25 - 11:35 a.m. - Disease Economics: The Impact of Arthritis
Description: With the baby boomer generation closing in on the “arthritis years” how severely will this impact the health care system and the U.S. economy? What is the government doing to handle these demands?
Speakers: Captain Joe Sniezek, MD, MPH, U.S. Public Health Service
Chief, Arthritis Program, National Center for Chronic Disease Prevention and Health Promotion
Beth Richards, program manager for the State of Missouri Arthritis & Osteoarthritis
Marty Steffens, Society of American Business Editors and Writers Chair in Business and Financial Journalism, MU School of Journalism
11:35 - 12:30 p.m. - Lunch
12:30 - 1:25 p.m. - Controversies in Drug Regulation
Description: The FDA is often harshly criticized when it releases a drug to market with problem side effects. At the same time, the agency is under constant attack for being too slow to approve drugs that could save lives and end suffering for thousands. Dr. Steven Galson, acting director of the Center for Drug Evaluation and Research at the FDA, discusses the risk/benefit considerations that pertain to the drug approval process.
Speaker: Dr. Steven Galson, acting director, Center for Drug Evaluation and Research, FDA
1:25 - 1:35 p.m. - Break
1:35 - 2:45 p.m. - The Real Statistics and the Real People
Description:Finding statistics and analyzing data to support a medical story can make any reporter cringe. How do you find those compelling statistics and still have time to interpret them before your deadline? Experts in computer-assisted reporting will demonstrate valuable techniques to enhance your research skills on complicated health and science issues by use of numbers and quantitative data. Then get the scoop from an expert statistician of easy ways to interpret the data.
Speakers: Brant Houston, executive director of Investigative Reporters and Editors, Inc.
2:45 - 3 p.m. - Break
3 - 4 p.m. - Unconventional Coverage: Expanding Your Ideas About Health Stories
Description: Learn how a top editor approaches medical issues, digs into stories, and finds the right stories. Learn about tips, contacts and story ideas to take back to the newsroom. Health care innovations will also be covered.
Speakers: Geneva Overholser, Curtis B. Hurley Chair in Public Affairs Reporting, MU School of Journalism, former ombudsman at The Washington Post
Michael Grinfeld, associate professor, MU School of Journalism
|
|